Wits University will begin its 2nd Covid-19 vaccine trials this week

Wits University will begin its 2nd Covid-19 vaccine trials this week

- The second South African Covid-19 vaccination clinical trials will begin this week

- Wits Professor of Vaccinology, Shabir Madhi, will lead the Novavax clinical trial in South Africa

- The Phase 2 trial in South Africa will evaluate if the nanoparticle S-protein in the Covid-19 vaccine known as NVX-CoV2373 protects against Covid-19 disease in adults aged 18 to 64 years old

PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly.co.za News on your News Feed!

The second round of Covid-19 vaccination trials is set to kick off this week in South Africa. Wits University will be screening participants for the trial today.

In the second phase of vaccination trials, SA will be evaluating if the nanoparticle S-protein in the Covid-19 vaccine known as NVX-CoV2373 protects against Covid-19 disease in adults aged 18 to 64 years old.

NVX-CoV2373 is produced by the biotech company, Novavax (Maryland, USA). Novavax is a late-stage biotechnology company that develops next-generation vaccines for serious infectious diseases.

READ ALSO: Somizi Mhlongo’s spicy photo has tongues wagging on social media

The trial will once again be led by Shabhir Madhi, a wits Professor of Vaccinology. Shabhir previously collaborated with Novavax as a lead investigator on the RSV vaccine for pregnant women, which aimed to prevent the most common cause of pneumonia in babies.

Shabhir had this to say about beginning phase two vaccination trials.

“The major motivation for Covid-19 vaccines being evaluated at an early stage in South Africa is to generate evidence in the African context on how well these vaccines work in settings such as our own.
"This would enable informed decision-making when advocating for the adoption of this [NVX-CoV2373 vaccine candidate] or other Covid-19 vaccines in African countries, once they are shown to be safe and effective.
"Participating in the clinical development of these vaccines at the outset will assist in advocating for South Africans to be amongst the first in line to access these life-saving vaccines, once they become available.”
Wits University will begin its second Covid-19 vaccine trials this week

Professor Shabhir Madhi will lead the second phase of vaccination trials in SA this week. Source: Facebook/Wits University of Witswatersrand
Source: Facebook

READ ALSO: Zodwa Wabantu cans herself over Vusi Ngubane’s fake R8 purchase

Meanwhile, in other Briefly.co.za news, Minister of Cooperative Governance and Traditional Affairs Nkosazana Dlamini-Zuma has addressed the nation on Level 2 lockdown updates. She revealed that alcohol and cigarettes will be back on sale and the economy will open up more.

South Africans were briefed on the new Level 2 lockdown regulations which were gazetted this week after President Cyril Ramaphosa announced that South Africa would move to lockdown Level 2.

Generally, restrictions across the board were relaxed and inter-provincial travel will resume as well as family visits (with restrictions). The news was met with celebrations across the country as people found the prospect of life going (a little) back to normal exciting.

Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!

Source: Briefly.co.za

Online view pixel